Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, Jia-Yi, Englund, Elisabet, Holton, Janice L, Soulet, Denis, Hagell, Peter, Lees, Andrew J, Lashley, Tammaryn, Quinn, Niall P, Rehncrona, Stig, Björklund, Anders, Widner, Håkan, Revesz, Tamas, Lindvall, Olle, Brundin, Patrik·2008·Nature Medicine

DOI 10.1038/nm1746

Cited by (1,002)

Items 401–500 of 1,002

Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease
Karlijn J. Doorn, Paul John Lucassen, H. W. G. M. Boddeke, Marloes Prins, Henk W. Berendse, Benjamin Drukarch, Anne‐Marie van Dam · 2012 · Progress in Neurobiology
A patient with Huntington’s disease and long-surviving fetal neural transplants that developed mass lesions
Christopher Dirk Keene, Rubens C. Chang, James B. Leverenz, Oleg V. Kopyov, Susan Perlman, Robert F. Hevner, Donald E. Born, Thomas D. Bird, Thomas Jude Montine · 2008 · Acta Neuropathologica
Prion-like propagation of pathology in Parkinson disease
Laura A. Volpicelli‐Daley, Patrik Brundin · 2018 · Handbook of clinical neurology
Review: Prion‐like mechanisms of transactive response DNA binding protein of 43 kDa ( TDP ‐43) in amyotrophic lateral sclerosis ( ALS )
Phillip Smethurst, Katie C. L. Sidle, John Hardy · 2014 · Neuropathology and Applied Neurobiology
Old and new challenges in Parkinson's disease therapeutics
Ana O. Pires, Fábio Gabriel Teixeira, Bárbara Mendes-Pinheiro, Sofia Cravino Serra, Nuno Sousa, António José Salgado · 2017 · Progress in Neurobiology
Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells
Gabriel Gustafsson, Camilla Lööv, Emma Persson, Diana F. Lázaro, Shuko Takeda, Joakim J. E. Bergström, Anna Erlandsson, Dag Sehlin, Leonora Balaj, Bence György et al. · 2018 · Cellular and Molecular Neurobiology
Specific Knockdown of α-Synuclein by Peptide-Directed Proteasome Degradation Rescued Its Associated Neurotoxicity
Jing Tao Qu, Xiaoxi Ren, Fenqin Xue, Yi He, Ruihua Zhang, Yan Zheng, Haixia Huang, Wei Wang, Jianliang Zhang · 2020 · Cell chemical biology
Metal ions shape α-synuclein
Rani Moons, Albert Konijnenberg, Carl Mensch, Roos Van Elzen, Christian Johannessen, Stuart R. Maudsley, Anne‐Marie Lambeir, Frank Sobott · 2020 · Scientific Reports
Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers
Ugalde, Cathryn L., Finkelstein, David I., Lawson, Victoria A., Hill, Andrew F. · 2016 · Journal of Neurochemistry
Structural Typing of Systemic Amyloidoses by Luminescent-Conjugated Polymer Spectroscopy
K. Peter R. Nilsson, Kristian Ikenberg, Andreas Åslund, Sophia Fransson, Peter Konradsson, Christoph Röcken, Holger Moch, Adriano Aguzzi · 2009 · American Journal Of Pathology
Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra
Yang Heng, Qiu-Shuang Zhang, Zheng Mu, Jin‐Feng Hu, Yu‐He Yuan, Nai‐Hong Chen · 2015 · Toxicology Letters
Molecular changes in the postmortem parkinsonian brain
Damien Toulorge, Anthony H.V. Schapira, Rodolphe Hajj · 2016 · Journal of Neurochemistry
Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a P arkinson disease patient
Jeffrey H. Kordower, Christopher G. Goetz, Yaping Chu, Glenda Margaret Halliday, Daniel A. Nicholson, Timothy F. Musial, David J. Marmion, A. Jon Stoessl, Vesna Sossi, Thomas B. Freeman et al. · 2016 · Annals of Neurology
Cell Therapeutics in Parkinson's Disease
Olle Lindvall, Anders Björklund · 2011 · Neurotherapeutics
Prions and Protein Assemblies that Convey Biological Information in Health and Disease
David W. Sanders, Sarah K. Kaufman, Brandon B. Holmes, Marc I. Diamond · 2016 · Neuron
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy
Timothy Rittman, Mikail Rubinov, Petra E. Vértes, Ameera X. Patel, Cedric E. Ginestet, Boyd C. P. Ghosh, Roger A. Barker, Maria Grazia Spillantini, Edward Thomas Bullmore, James Benedict Rowe · 2016 · Neurobiology of Aging
Replacing what’s lost: a new era of stem cell therapy for Parkinson’s disease
Yong Fan, Winanto Winanto, Shi‐Yan Ng · 2020 · Translational Neurodegeneration
Neurotrophic Factors in Parkinson’s Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain
Olesja M. Bondarenko, Märt Saarma · 2021 · Frontiers in Cellular Neuroscience
Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
Francesco Agostini, Anna Masato, Luigi Bubacco, Marco Bisaglia · 2021 · International Journal of Molecular Sciences
Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
Shuanglong Yi, Linfang Wang, Honglei Wang, Margaret Su-chun Ho, Shiping Zhang · 2022 · International Journal of Molecular Sciences
The triple power of D³: Protein intrinsic disorder in degenerative diseases
Vladimir Nikolaevich Uversky · 2014 · Frontiers in bioscience
Visualization of cell-to-cell transmission of mutant huntingtin oligomers
Federico Herrera, Sandra Tenreiro, Leonor Miller‐Fleming, Tiago F. Outeiro · 2011 · PLoS Currents
Frontal Cortex Neuropathology in Dementia Pugilistica
Tommy Saing, Malcolm B. Dick, Peter T. Nelson, Ronald C. Kim, David H. Cribbs, Elizabeth Head · 2011 · Journal of Neurotrauma
Development of P assive I mmunotherapies for S ynucleinopathies
Ann‐Louise Bergström, Pekka Kallunki, Karina Fog · 2015 · Movement Disorders
Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
Sonia George, Patrik Brundin · 2015 · Journal of Parkinson s Disease
ɑ‐Synuclein strains and the variable pathologies of synucleinopathies
Wouter Peelaerts, Veerle Baekelandt · 2016 · Journal of Neurochemistry
Strategies for bringing stem cell-derived dopamine neurons to the clinic
Agnete Kirkeby, Malin Parmar, Roger A. Barker · 2017 · Progress in brain research
Exosomes from patients with Parkinson’s disease are pathological in mice
Chao Han, Nian Xiong, Xingfang Guo, Jinsha Huang, Kai Ma, Ling Liu, Yun Fei Xia, Yan Shen, Jie Li, Haiyang Jiang et al. · 2019 · Journal of Molecular Medicine
A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson’s Disease
George K. Tofaris · 2017 · Journal of Parkinson s Disease
Engineering synucleinopathy‐resistant human dopaminergic neurons by CRISPR ‐mediated deletion of the SNCA gene
Yixi Chen, Karamjit Singh Dolt, Marco Kriek, TERRY S. BAKER, Patrick Mark Downey, Nicola J. Drummond, Maurice A. Canham, Ammar Natalwala, Susan J. Rosser, Tilo Kunath · 2018 · European Journal of Neuroscience
Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity
Anna Villar‐Piqué, Tomás Lopes da Fonseca, Ricardo Sant’Anna, Éva M. Szegő, Luis Fonseca‐Ornelas, Raquel Pinho, Anita Čarija, Ellen Gerhardt, Caterina Masaracchia, Enrique Abad Gonzalez et al. · 2016 · Proceedings of the National Academy of Sciences
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank Boess, Kirsten I. Taylor, Benedicte Ricci, Brit Mollenhauer, Werner H Poewe, Anne Boulay, Judith Anzures‐Cabrera, Annamarie Vogt, Maddalena Marchesi et al. · 2021 · Frontiers in Neurology
Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment
Ayami Okuzumi, Masaru Kurosawa, Taku Hatano, Masashi Takanashi, Nojiri Shuuko, Takeshi Fukuhara, Tomoyuki Yamanaka, Haruko Miyazaki, Saki Yoshinaga, Yoshiaki Furukawa et al. · 2018 · Acta Neuropathologica Communications
The significance of defining preclinical or prodromal Parkinson's disease
C. Warren Olanow, Jose Angel Obeso · 2012 · Movement Disorders
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
Amanda N. Sacino, Mieu Brooks, Nicholas H. McGarvey, Alex B. McKinney, Michael A Thomas, Yona Levites, Yong Ran, Todd Eliot Golde, Benoit I. Giasson · 2013 · Acta Neuropathologica Communications
Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential
Nelson Ferreira, Hjalte Gram, Zachary A. Sorrentino, Emil Gregersen, Sissel Ida Schmidt, Lasse Reimer, Cristine Betzer, Clara Pérez-Gozalbo, Marjo Beltoja, Madhu Nagaraj et al. · 2021 · Acta Neuropathologica
Extracellular Vesicles for the Diagnosis and Treatment of Parkinson’s Disease
Raghavendra Upadhya, Ashok Kumar Shetty · 2021 · Aging and Disease
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
Pauline Wales, Raquel Pinho, Diana F. Lázaro, Tiago F. Outeiro · 2013 · Journal of Parkinson s Disease
α-Synuclein-carrying extracellular vesicles in Parkinson’s disease: deadly transmitters
Dimitry A. Chistiakov, Alexander A. Chistiakov · 2016 · Acta Neurologica Belgica
De novo generation of prion strains
David W. Colby, Stanley B. Prusiner · 2011 · Nature Reviews Microbiology
Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson’s Disease
Daniel Aghaie Madsen, Sissel Ida Schmidt, Morten Blaabjerg, Morten Meyer · 2021 · Cells
Pregnancy-Associated Progenitor Cells Differentiate and Mature into Neurons in the Maternal Brain
Xiao Xia Zeng, Kian Hwa Tan, Ailing Yeo, Piriya Sasajala, Xiao‐Wei Tan, Zhi Cheng Xiao, Gavin Stewart Dawe, Gerald Udolph · 2010 · Stem Cells and Development
Adult Hippocampal Neurogenesis in Parkinson’s Disease: Impact on Neuronal Survival and Plasticity
Martin Regensburger, Iryna Prots, Beate Winner · 2014 · Neural Plasticity
Exosomes-associated neurodegeneration and progression of Parkinson's disease.
Isabella Russo, Luigi Bubacco, Elisa Greggio · 2012 · Europe PMC (PubMed Central)
Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
Marie-Laure Arotçarena, Margaux Teil, Benjamin Dehay · 2019 · Cells
RETRACTED: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
Brian J. Spencer, Sharareh Emadi, Paula Desplats, Simona Eleuteri, Sarah A. Michael, Kori Ann Kosberg, Jay Shen, Edward M. Rockenstein, Christina Patrick, Anthony Adame et al. · 2014 · Molecular Therapy · Retracted
Evidence of distinct α-synuclein strains underlying disease heterogeneity
Sara A. M. Holec, Amanda L. Woerman · 2020 · Acta Neuropathologica
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
Darren M. O’Hara, Grishma N. Pawar, Suneil Kumar Kalia, Lorraine V. Kalia · 2020 · Frontiers in Neuroscience
A cell culture model for monitoring α-synuclein cell-to-cell transfer
Juan F. Reyes, Tomas T. Olsson, Jennifer T. Lamberts, Michael J. Devine, Tilo Kunath, Patrik Brundin · 2014 · Neurobiology of Disease
Oligodendroglial α‐synucleinopathy‐driven neuroinflammation in multiple system atrophy
Hoffmann, Alana, Ettle, Benjamin, Battis, Kristina, Reiprich, Simone, Schlachetzki, Johannes C. M., Masliah, Eliezer, Wegner, Michael, Kuhlmann, Tanja, Riemenschneider, Markus J., Winkler, Jürgen · 2019 · Brain Pathology
Ubiquitin, Autophagy and Neurodegenerative Diseases
Yoshihisa Watanabe, Katsutoshi Taguchi, Masaki Tanaka · 2020 · Cells
Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice
Savannah M. Rocha, Collin M. Bantle, Tawfik Aboellail, Debotri Chatterjee, Richard Jay Smeyne, Ronald B. Tjalkens · 2022 · Neurobiology of Disease
Ghrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection
Jacqueline A. Bayliss, Zane Bruce Andrews · 2013 · Therapeutic Advances in Endocrinology and Metabolism
Mesenchymal Stem Cells Inhibit Transmission of α-Synuclein by Modulating Clathrin-Mediated Endocytosis in a Parkinsonian Model
Se Hee Oh, Hana Kim, Hyun Jung Park, Jin Young Shin, Eun-Jin Bae, Mun Kyung Sunwoo, Seung‐Jae Lee, Phil Hyu Lee · 2016 · Cell Reports
Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC
Kazunori Sano, Ryuichiro Atarashi, Katsuya Satoh, Daisuke Ishibashi, Takehiro Nakagaki, Yasushi Iwasaki, Mari Yoshida, Shigeo Murayama, Kenichi Mishima, Noriyuki Nishida · 2017 · Molecular Neurobiology
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease
Christian Hansen, Jiayi Li · 2012 · Trends in Molecular Medicine
The small GTPase Rab11 co-localizes with -synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity
Oldriska Chutna, Susana A. Gonçalves, Anna Villar‐Piqué, Patrícia Silva Guerreiro, Zrinka Marijanovic, Tiago Mendes, Jose Silva Ramalho, Evangelia Emmanouilidou, Salvador Ventura, Jochen Klucken et al. · 2014 · Human Molecular Genetics
Treatment of Parkinson's disease using cell transplantation
Olle Lindvall · 2015 · Philosophical Transactions of the Royal Society B Biological Sciences
Interactions between Calcium and Alpha-Synuclein in Neurodegeneration
Alexandre Nay Rcom-H'cheo-Gauthier, Jacob Goodwin, Dean L. Pountney · 2014 · Biomolecules
In vitro aggregation assays for the characterization of α-synuclein prion-like properties
Joanna Narkiewicz, Gabriele Giachin, Giuseppe Legname · 2014 · Prion
A novel, high‐efficiency cellular model of fibrillar α‐synuclein inclusions and the examination of mutations that inhibit amyloid formation
Elisa A. Waxman, Benoit I. Giasson · 2010 · Journal of Neurochemistry
Targeting mitochondrial dysfunction in neurodegenerative disease: Part II
Victoria Burchell, Sonia Gandhi, Emma Deas, Nicholas William Wood, Andrey Y. Abramov, Hélène Plun‐Favreau · 2010 · Expert Opinion on Therapeutic Targets
Novel DNA Aptamers for Parkinson’s Disease Treatment Inhibit α-Synuclein Aggregation and Facilitate its Degradation
Zheng Yuan, Jing Tao Qu, Fenqin Xue, Yan Zheng, Bo Yang, Yongchang Chang, Hui Yang, Jianliang Zhang · 2018 · Molecular Therapy — Nucleic Acids
Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axis
Szu‐Ju Chen, Chin‐Hsien Lin · 2022 · Journal of Biomedical Science
The Contribution of α -Synuclein Spreading to Parkinson’s Disease Synaptopathy
Francesca Longhena, Gaia Faustini, Cristina Missale, Marina Pizzi, PierFranco Spano, Arianna Bellucci · 2017 · Neural Plasticity
Noninvasive delivery of an α‐synuclein gene silencing vector with magnetic resonance–guided focused ultrasound
Kristiana Xhima, Fadl Nabbouh, Kullervo Hynynen, Isabelle Aubert, Anurag Tandon · 2018 · Movement Disorders
A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson’s disease
Lu, Jia, Wang, Chenfei, Cheng, Xin, Wang, Ruizhi, Yan, Xuehan, He, Pengju, Chen, Hongzhuan, Yu, Zhihua · 2022 · Journal of Neuroinflammation
The expression level of alpha-synuclein in different neuronal populations is the primary determinant of its prion-like seeding
Josquin Courte, Luc Bousset, Ysander von Boxberg, Catherine Villard, Ronald Melki, Jean‐Michel Peyrin · 2020 · Scientific Reports
Studying neurodegenerative diseases in culture models
Johannes C. M. Schlachetzki, Soraya Wilke Saliba, Antônio Carlos Pinheiro de Oliveira · 2013 · Brazilian Journal of Psychiatry
Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation
Philipp Capetian, Rolf Knoth, Jarek Maciaczyk, G. Pantazis, Margarethe Ditter, L. Bokla, G. Bernhard Landwehrmeyer, Balázs Volk, Guido Nikkhah · 2009 · Neuroscience
shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity
Susana A. Gonçalves, Diana Macedo, Helena Raquel, Pedro D. Simões, Flaviano Giorgini, Jose Silva Ramalho, Duarte C. Barral, Luís F. Moita, Tiago F. Outeiro · 2016 · PLoS Genetics
Inhibition of synucleinopathic seeding by rationally designed inhibitors
Sangwan, Smriti, Sahay, Shruti, Murray, Kevin A, Morgan, Sophie, Guenther, Elizabeth L, Jiang, Lin, Williams, Christopher K, Vinters, Harry V, Goedert, Michel, Eisenberg, David S · 2020 · eLife
Cellular mechanisms of protein aggregate propagation
Brandon B. Holmes, Marc I. Diamond · 2012 · Current Opinion in Neurology
Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: A potential therapy for Huntington's disease
Ofer Sadan, Noam Shemesh, Ran Barzilay, Michal Dadon-Nachum, Tamar Blumenfeld‐Katzir, Yaniv Assaf, Moshe Yeshurun, Ruth Djaldetti, Yoram Cohen, Eldad Melamed et al. · 2012 · Experimental Neurology
Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants
Afsaneh Gaillard, Mickaël Decressac, Isabelle Frappé, Pierre‐Olivier Fernagut, Laetitia Prestoz, Stephan Besnard, Mohamed Jaber · 2009 · Neurobiology of Disease
(−)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of α-synuclein, and protects PC12 cells against α-synuclein-induced toxicity
Juan Zhao, Qingnan Liang, Qing Yuan Sun, Congheng Chen, Lihui Xu, Yu Ding, Ping Zhou · 2017 · RSC Advances
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Margaux Teil, Marie-Laure Arotçarena, Emilie Faggiani, Florent Laferrière, Erwan Bézard, Benjamin Dehay · 2020 · Biomolecules
Animal models of brain-first and body-first Parkinson's disease
Nathalie Van Den Berge, Ayşe Ulusoy · 2021 · Neurobiology of Disease
Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy
Jacob I. Ayers, Joanne Lee, Octovia Monteiro, Amanda L. Woerman, Ann Lazar, Carlo Condello, Nick A. Paras, Stanley B. Prusiner · 2022 · Proceedings of the National Academy of Sciences
α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
Yemima R. Butler, Yuqing Liu, Ramhari Kumbhar, Peiran Zhao, Kundlik Gadhave, Ning Wang, Yanmei Li, Xiaobo Mao, Wenjing Wang · 2022 · Nature Communications
Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson’s Disease
Tahereh Sohrabi, Behnaz Mirzaei-Behbahani, Ramin Zadali, Mitra Pirhaghi, Ludmilla A. Morozova‐Roche, Ali Akbar Meratan · 2023 · Journal of Molecular Biology
Gene Therapy in Parkinsonʼs Disease
Li Feng, Kathleen A. Maguire‐Zeiss · 2010 · CNS Drugs
Dopaminergic transplantation for parkinson's disease: Current status and future prospects
C. Warren Olanow, Jeffrey H. Kordower, Anthony Edward Lang, Jose Angel Obeso · 2009 · Annals of Neurology
Antidepressants reduce neuroinflammatory responses and astroglial alpha‐synuclein accumulation in a transgenic mouse model of multiple system atrophy
Elvira Valera, Kiren K. Ubhi, Michael Mante, Edward M. Rockenstein, Eliezer Masliah · 2013 · Glia
Proteolytic Cleavage of Extracellular α-Synuclein by Plasmin
Kwang Soo Kim, Yu Ree Choi, Ji Young Park, Jung-Ho Lee, Dong Kyu Kim, Seung‐Jae Lee, Seung R. Paik, Ilo Jou, Sang Myun Park · 2012 · Journal of Biological Chemistry
Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy
Subrata Pramanik, Yanuar Alan Sulistio, Klaus Heese · 2016 · Molecular Neurobiology
Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy
Andrii Domanskyi, Märt Saarma, Mikko Airavaara · 2015 · Human Gene Therapy
Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays
Niccolò Candelise, Matthias Schmitz, Katrin Thüne, Maria Cramm, Alberto Rábano, Saima Zafar, Erik Stoops, Hugo Vanderstichele, Anna Villar‐Piqué, Franc Llorens et al. · 2020 · Translational Neurodegeneration
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpędek‐Kamińska, Ireneusz Majsterek · 2023 · International Journal of Molecular Sciences
Clinical translation of stem cell transplantation in Parkinson's disease
Olle Lindvall · 2015 · Journal of Internal Medicine
Extracellular neurosin degrades α-synuclein in cultured cells
Harutsugu Tatebe, Yoshihisa Watanabe, Takashi Kasai, Toshiki Mizuno, Masanori Nakagawa, Masaki Tanaka, Takahiko Tokuda · 2010 · Neuroscience Research
GABA transmission via ATP-dependent K + channels regulates α-synuclein secretion in mouse striatum
Evangelia Emmanouilidou, Georgia Minakaki, Maria V. Keramioti, Mary Xylaki, Evangelos Balafas, Margarita Chrysanthou‐Piterou, Ismini Kloukina, Kostas Vekrellis · 2016 · Brain
Nanomechanical properties of distinct fibrillar polymorphs of the protein α-synuclein
Ali Makky, Luc Bousset, Jérôme Polesel‐Maris, Ronald Melki · 2016 · Scientific Reports
SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation
Rafaa Zeineddine, Jay Pundavela, Lisa Corcoran, Elise M. Stewart, Dzung Do‐Ha, Monique Bax, Gilles J. Guillemin, Kara L. Vine, Danny M. Hatters, Heath W. Ecroyd et al. · 2015 · Molecular Neurodegeneration
Developing dopaminergic cell therapy for Parkinson's disease—give up or move forward?
Olle Lindvall · 2013 · Movement Disorders
Selective neuronal vulnerability in Parkinson's disease
Patricia González‐Rodríguez, Enrico Zampese, Dalton James Surmeier · 2020 · Progress in brain research
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
Christina E. Toomey, Wendy Heywood, James R. Evans, Joanne Lachica, Sarah N. Pressey, Sandrine C. Foti, Mesfer Mohammad Al Shahrani, Karishma D’Sa, Iain Parry Hargreaves, Simon Heales et al. · 2022 · Acta Neuropathologica Communications
Cell replacement therapy for Parkinson's disease
Ruwani Wijeyekoon, Roger A. Barker · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
Wojciech Bobela, Patrick Aebischer, Bernard Laurent Schneider · 2015 · Biomolecules
Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation
Dharmin Rokad, Shivani Ghaisas, Dilshan S. Harischandra, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, Anumantha G. Kanthasamy · 2016 · Brain Research Bulletin